Clinical trials: Meales-mumps-rubella Vaccine

Meales-mumps-rubella Vaccine

MMR at 6 Months Trial

• Completed
• Age: 5 to 7 months
• Phase 4

Randomised, double-blind clinical trial to test humoral and cellular immunogenicity, and potential in-direct beneficial effect of the MMRvaxpro-vaccine administered at 6 months of age

Trial name

NCT03780179

Testing

MMRvaxpro

Where

2 sites in Denmark

Volunteers

6,540 people

Sponsor

Copenhagen University Hospital, Rigshospitalet